LexAurum Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$740K Buy
2,941
+537
+22% +$116K 0.09% 187
2026
Q1
$523K Buy
+2,404
New +$533K 0.07% 219
2025
Q3
$567K Buy
2,447
+657
+37% +$134K 0.08% 185
2025
Q2
$332K Buy
1,790
+154
+9% +$28.6K 0.05% 256
2025
Q1
$343K Sell
1,636
-73
-4% -$14.2K 0.07% 242
2024
Q4
$304K Buy
1,709
+549
+47% +$101K 0.06% 261
2024
Q3
$229K Buy
+1,160
New +$216K 0.05% 278
2024
Q2
Sell
-1,152
Closed -$210K 300
2024
Q1
$210K Buy
+1,152
New +$199K 0.05% 275
2021
Q4
Sell
-7,735
Closed -$834K 251
2021
Q3
$834K Buy
7,735
+138
+2% +$15.8K 0.25% 98
2021
Q2
$856K Buy
7,597
+440
+6% +$49.6K 0.25% 97
2021
Q1
$775K Buy
7,157
+196
+3% +$21K 0.26% 89
2020
Q4
$746K Buy
6,961
+2,237
+47% +$215K 0.27% 92
2020
Q3
$414K Buy
4,724
+691
+17% +$65.1K 0.17% 122
2020
Q2
$396K Buy
4,033
+552
+16% +$48.6K 0.22% 102
2020
Q1
$265K Buy
+3,481
New +$297K 0.18% 125

Other funds holding ABBV